HARBIN, China, July 16 /PRNewswire-Asia-FirstCall/ —
China Sky One Medical, Inc. (“China Sky One Medical” or “the
Company”) (Nasdaq: CSKI), a leading fully integrated pharmaceutical
company producing over-the-counter drugs in the People’s Republic of China (“PRC”),
today announced that Mr. Stanley
Hao, the Company’s Chief Financial Officer and Secretary,
will be unreachable by investors for a period of time due to health
reasons. Until he regains full capacity, investors should contact
CCG Investor Relations with any inquiries.
Mr. Yan-qing Liu, China Sky One Medical’s Chairman and Chief
Executive Officer, commented, “We wish Stanley a speedy recovery.
During this time, Mr. Yu-kun Zhang, the Company’s Manager of
Finance, will continue to assist us with meeting our financial,
accounting and reporting needs.”
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding
company. The Company engages in the manufacturing, marketing and
distribution of pharmaceutical, medicinal and diagnostic products.
Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical
Science and Technology Company (“TDR”), Harbin First
Bio-Engineering Company Limited (“First”), Heilongjiang Tianlong
Pharmaceutical, Inc. (“Tianlong”) and Peng Lai Jin Chuang
Pharmaceutical Company (“Jin Chuang”) the Company manufactures and
distributes over-the-counter pharmaceutical products, which make up
its major revenue source. For more information, visit